Managing Director's Message

In July 2004, Apotex Inc. acquired the GenRx business in Australia. In September 2007, GenRx changed its name to Apotex Pty Ltd (Apotex). Today, Apotex sells around 90 products in Australia in varying forms and strengths.

Our mission is to be a part of one of the world's most successful independent pharmaceutical companies in research and development, quality, manufacturing, sales and customer service.

Over the coming years, the Australian pharmaceutical industry will undergo rapid transformation as medical resources continue to be stretched and added pressure is placed on the healthcare system. At Apotex, we believe that a pharmaceutical company's ability to adapt to these changes will provide a true indication of its sustainability in the market place.

Apotex's key focus is to build and maintain relationships with our customers through the development of value-added pharmacy programmes and materials, coupled with a sound business offering. In addition, continued investment in our people and further involvement of our management systems will ensure your business is equipped with products, knowledge and support required for a sustainable future.

We look forward to supporting the profession and business of pharmacy as pharmacists position themselves to take advantage of the opportunities that this changing market presents.

Roger Millichamp
Managing Director
Apotex Pty Ltd